List of PDP proposals submitted in the 2017 s round # PRODUCT PUBLIC INSTITUTION PRIVATE ENTITY PROTOCOL # 1 adalimumab Butantan Libbs 2 adalimumab 3 adalimumab TECPAR 4 betagalsidase TECPAR 5 capecitabine IVB 6 capecitabine FUNED 7 capecitabine LAFEPE Bionovis S/A Merck S/A Ares Trading Orygen Biotecnologia S/A Pfizer Incorporated Genzyme Corporation (Holder- EUA) Genzyme Ireland LTD (Holder) Genzyme Brasil Ltda (Affiliate) 20170115 20170085 20170007 20170029 20170054 20170035 20170111 8 capecitabine LAQFA 9 certolizumab 10 coagulation factor concentrate (factors i,ix, vii recombinant, viii associated with willebrand factor, viii plasma, xiii) TECPAR 11 daclatasvir LFM 12 daclatasvir 13 daclatasvir LAQFA 14 daclatasvir FURP 15 darunavir LAFEPE 16 darunavir LAQFA 17 darunavir FURP 18 darunavir + ritonavir IVB * Globe Química S.A Octapharma AG Janssen-Cilag Farmaceutica Ltda Aurobindo Pharma Indústria. 20170042 0170108 20170050 20170008 20170127 20170068 20170031 20170116 20170069 20170048 20170061 Rio de Janeiro Sao Paulo Tokyo lickslegal.com 1/5
19 dasatinib IVB 20 dasatinib FUNED 21 dasatinib LAQFA 22 dasatinib FURP 23 dolutegravir LAFEPE 24 dolutegravir LAQFA 25 dolutegravir FURP 26 dolutegravir + lamivudine IVB 27 entricitabine + tenofovir 28 entricitabine + tenofovir IVB 29 entricitabine + tenofovir NUPLAM 30 entricitabine + tenofovir 31 erlotinib IVB 32 erlotinib FUNED 33 erlotinib LAFEPE 34 erlotinib LAQFA 35 erlotinib TECPAR 36 everolimus 37 everolimus NUPLAM 38 everolimus 39 everolimus FURP farmacêutica S/A Aurobindo Pharma Indústria Blanver farmoquímica e Gilead Sciences Farmacêutica do Brasil Ltda Nortec S/A ITF Chemical Ltda Cipla Limited Libbs Farmacêutica LTDA 20170063 20170027 20170070 20170065 20170118 20170071 20170055 20170019 20170039 20170022 20170117 20170098 20170064 20170036 20170114 20170072 20170033 20170021 20170105 20170095 20170049 Rio de Janeiro Sao Paulo Tokyo lickslegal.com 2/5
40 everolimus TECPAR 41 fingolimod LIFESA 42 fingolimod LAFEPE 43 fingolimod NUPLAM 44 fingolimod FURP 45 golimumab 46 hydroxyurea IVB 47 hydroxyurea 48 imiglucerase TECPAR 49 50 51 52 insulin aspart (ultra-fast rapid-acting insulin) Butantan FUNED 53 lenalidomide FUNED 54 lenalidomide TECPAR 55 mycophenolate sodium LQFEX 56 mycophenolate sodium IVB 57 mycophenolate sodium 58 mycophenolate sodium FURP 59 nilotinib IVB 60 nilotinib LAQFA 61 nivolumab 62 oseltamivir LAFEPE Novartis Biociências S/A Novartis Biociência S/A Janssen Genzyme Corporation - (Holder EUA) Genzyme Ireland LTD (Holder) Genzyme do Brasil Ltda (Affiliate) INDAR, PrJSC Sanofi-Aventis Deutschland GmbH Biomm S.A Gan & Lee Pharmaceuticals INDAR, PrJSC a Natcofarma do Brasil a Natcofarma do Brasil Novartis Pharma AG 20170026 20170119 20170112 20170056 20170058 20170081 20170053 20170096 20170012 20170129 20170104 20170093 20170106 20170014 20170043 20170013 20170017 20170084 20170052 20170018 20170073 20170107 20170125 Rio de Janeiro Sao Paulo Tokyo lickslegal.com 3/5
63 oseltamivir LAQFA 64 oseltamivir FURP 65 palivizumab Butantan Libbs 66 pembrolizumab 67 pramipexole NUPLAM 68 simeprevir LFM 69 simeprevir 70 simeprevir LAQFA 71 simeprevir FURP 72 sofosbuvir LFM 73 sofosbuvir 74 sofosbuvir LAFEPE 75 sofosbuvir LAQFA 76 sofosbuvir FURP 77 supplement of vitamins and minerals in powder (micronutrients) LFM 78 teriflunomide LFM 79 teriflunomide NUPLAM 80 81 UFCG.. Gilead Sciences Farmacêutica do Brasil Ltda Nortec S/A DSM Produtos Nutricionais BRASIL S/A LAQFA* Natco Pharma Limited Innovita Biological Technology Co., Ltd. Genbody Inc. 20170074 20170057 20170110 20170099 20170094 20170023 20170130 20170075 20170066 20170025 20170037 20170124 20170076 20170080 20170040 20170034 20170132 20170051 20170101 Rio de Janeiro Sao Paulo Tokyo lickslegal.com 4/5
82 83 tocilizumab FURP Innovita Biological Technology Co., Ltd. Ares Trading (Merck S/A, Merck Serono) 20170046 20170087 * This seems to be a clerical mistake since /LAQFA is a public institution, not a Private Entity. Rio de Janeiro Sao Paulo Tokyo lickslegal.com 5/5